Ligands for peroxisome proliferator-activated receptors α and γ inhibit chemically induced colitis and formation of aberrant crypt foci in rats

Cancer Research

Volumn 61, Issue 6, 2001, Pages 2424-2428

  Tanaka, Takuji ^a   Kohno, Hiroyuki ^a   Yoshitani, Shin ichiro ^a   Takashima, Shigeki ^a   Okumura, Ataru ^b   Murakami, Akira ^c   Hosokawa, Masashi ^d  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b ANJO KOSEI HOSPITAL   (Japan)

^c KINKI UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BEZAFIBRATE; DEXTRAN SULFATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; TREFOIL PEPTIDE; TROGLITAZONE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLITIS; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG EFFICACY; INTESTINE CRYPT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; BEZAFIBRATE; CELL DIVISION; CHROMANS; COLITIS; COLONIC NEOPLASMS; DEXTRAN SULFATE; GROWTH SUBSTANCES; INTESTINAL MUCOSA; LIGANDS; MALE; MUCINS; MUSCLE PROTEINS; NEUROPEPTIDES; NUCLEOLUS ORGANIZER REGION; PEPTIDES; PRECANCEROUS CONDITIONS; PROTEINS; RATS; RATS, INBRED F344; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SILVER STAINING; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

EID: 0035866756     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Colorectal cancer in inflammatory bowel disease
2. Asian studies of cancer chemoprevention: Latest clinical results
3. Colitis-related rat colon carcinogenesis induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate
4. Review: Nitric oxide and oxygen radicals in infection, inflammation, and cancer
5. Changes in colonic inflammation induced by dextran sulfate sodium (DSS) during short- and long-term administration of rebamipide
6. Induction of colorectal squamous cell carcinomas in rats by dextran sulfate sodium
7. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen
8. Aberrant crypts: Putative preneoplastlc foci in human colonic mucosa
9. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate
10. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer
11. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: A study of histopathology, β-catenin and p53 expression and the role of inflammation
12. An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer
13. PPARγ, the ultimate thrifty gene
14. Roles of PPARs in health and disease
15. Medical significance of peroxisome proliferator-activated receptor
16. Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa
17. Differential expression of the peroxisome proliferator-activated receptor γ (PPARγ) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse
18. Min/+ mice
19. Activators of the nuclear receptor PPARγ enhance colon polyp formation
20. Differentiation and reversal of malignant changes in colon cancer through PPARγ
21. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
22. A new ligand for the peroxisome proliferator-activated receptor-γ (PPARγ), GW7845, inhibits rat mammary carcinogenesis
23. The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers
24. 4 pathway to inflammatory control
25. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
26. Anti-inflammatory actions of 15-deoxy-Δ12, 14-prostaglandin J2 and troglitazone
27. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammation response
28. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
29. Trefoil peptides
30. Control of cell proliferation in cancer prevention
31. Promotion of colorecta, neoplasia in experimental murine ulcerative colitis
32. Temporal expression of trefoil peptides in the TGF-α knockout mouse after gastric ulceration
33. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
34. A xanthine oxidase inhibitor 1′-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats
35. Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis
36. NSAIDs as cancer preventive agents
37. Inhibitory effect of the non-steroidal anti-inflammatory drug, indomethacin on the naturally occurring carcinogen, 1-hydroxyanthraquinone in male AC1/N rats
38. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: Correlation with induction of heme oxygenase 1
39. PPAR-γ is selectively upregulated in Caco-2 cells by butyrate
40. Loss-of-function mutations in PPARγ associated with human colon cancer
41. Peroxisome proliferator-activated receptor γ induces growth arrest and differentiation markers of human colon cancer cells
42. Maturation of peroxisomes in differentiating human hepatoblastoma cells (HepG2): Possible involvement of the peroxisome proliferator-activated receptor (PPAR α)
43. A ligand of peroxisome proliferator-activated receptor γ, retinoids, and prevention of preneoplastic mammary lesions
44. Hepatic dysfunction associated with troglitazone
45. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers
46. The genetic toxicity of the peroxisome proliferator class of rodent hepatocarcinogen
47. Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: Mechanisms and lack of relevance for human health
48. Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo